Head-to-head · Cost-Efficiency Index
Medical Health Institute vs Oak
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Medical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteOak
Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage.
Visit OakThe verdict
Medical Health Institute takes it, leading the Cost-Efficiency Index 68 to 65. Medical Health Institute is a multi-service telehealth provider (weight loss, testosterone therapy, peptide therapy) advertising GLP-1 weight loss 'starting at $100/mo' a figure the company itself footnotes as contingent. Oak still earns a C — Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Medical Health Institute.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Medical Health Institute | Oak |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 65/100 |
| Semaglutide / mo | $100/mo (all doses, compounded) | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning |
| Tirzepatide / mo | Not disclosed | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning |
| Semaglutide / yr (modeled) | $1,200 | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | 45 states (list not published) |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #125 | #129 |
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
Oak
65/100Where the value is
- A non-injectable route alongside the two weekly injections — sublingual drops or tablets targeting the GLP-1 pathway — which most programs at this end of the ranking do not offer at all
- LegitScript-certified, provider-reviewed, no video call required, with free shipping and free health coaching included
- Its own comparison tables do print undiscounted floors — $167/mo on the homepage, $190/mo on /weight-loss — so a reader who scrolls past the hero at least sees figures that are not a package discount in a monthly slot
The tradeoffs
- It publishes NINE different "starting" prices — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term, a plan length or a billing cadence to not one of them
- The $119 and $185 in the homepage hero appear only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount presented as a monthly rate
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.